Kyverna Therapeutics

Kyverna Therapeutics

Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases. Our therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune
Founded
2018
Raised
$25M
Follow us
Latest funding
$25,000,000
Venture capital (Series A) - 2020
Vida Ventures Westlake Village BioPartners
Team Size
9
Employees
$25,000,000 Venture capital (Series A)
FinSMEs

Kyverna Therapeutics Raises $25M in Series A Funding